A novel LncRNA HITT forms a regulatory loop with HIF-1α to modulate angiogenesis and tumor growth

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in human diseases, particularly cancer.
• Functional annotation and experimental validation of lncRNAs remain limited.
• HIF-1α is a key regulator of cellular response to hypoxia and tumor progression.

Purpose of the Study:

• To identify and characterize a novel lncRNA involved in cancer regulation.
• To elucidate the mechanism by which this lncRNA affects cancer growth and angiogenesis.
• To explore the therapeutic potential of targeting this lncRNA-HIF-1α axis.

Main Methods:

• Identification and expression analysis of a novel lncRNA, HITT, in human cancers.
• In vivo studies using cancer cell xenografts to assess the impact of HITT on tumor growth and angiogenesis.
• Mechanism studies involving RNA-protein interactions, mRNA translation inhibition, and feedback loop analysis.
• Validation in human colon cancer tissues.

Main Results:

• A novel lncRNA, HITT (HIF-1α inhibitor at translation level), was identified and found to be decreased in multiple human cancers, correlating with advanced colon cancer stages.
• Restoration of HITT inhibited angiogenesis and tumor growth in vivo via HIF-1α inhibition at the translational level.
• HITT functions by sequestering YB-1 from the 5'-UTR of HIF-1α mRNA, and forms a feedback loop with HIF-1α via MiR-205.
• HITT downregulation is essential for hypoxia-induced HIF-1α expression.

Conclusions:

• The novel lncRNA HITT acts as a tumor suppressor by inhibiting HIF-1α translation.
• The HITT-HIF-1α axis represents a new regulatory mechanism for angiogenesis and tumor growth.
• HITT and its regulatory axis hold potential as therapeutic targets in cancer treatment.